Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

The factors associated with forensic psychiatrists' decisions in criminal responsibility and social dangerousness evaluations.

Mandarelli G, Carabellese F, Felthous AR, Parmigiani G, Del Casale A, Catanesi R, Montalbò D, Ferracuti S.

Int J Law Psychiatry. 2019 Sep - Oct;66:101503. doi: 10.1016/j.ijlp.2019.101503. Epub 2019 Oct 18.

PMID:
31706410
2.

Translating clinical findings to the legal norm: the Defendant's Insanity Assessment Support Scale (DIASS).

Parmigiani G, Mandarelli G, Meynen G, Carabellese F, Ferracuti S.

Transl Psychiatry. 2019 Nov 7;9(1):278. doi: 10.1038/s41398-019-0628-x.

PMID:
31699969
3.

Performance of breast cancer risk assessment models in a large mammography cohort.

McCarthy AM, Guan Z, Welch M, Griffin ME, Sippo DA, Deng Z, Coopey SB, Acar A, Semine A, Parmigiani G, Braun D, Hughes KS.

J Natl Cancer Inst. 2019 Sep 26. pii: djz177. doi: 10.1093/jnci/djz177. [Epub ahead of print]

PMID:
31556450
4.

Using Machine Learning and Natural Language Processing to Review and Classify the Medical Literature on Cancer Susceptibility Genes.

Bao Y, Deng Z, Wang Y, Kim H, Armengol VD, Acevedo F, Ouardaoui N, Wang C, Parmigiani G, Barzilay R, Braun D, Hughes KS.

JCO Clin Cancer Inform. 2019 Sep;3:1-9. doi: 10.1200/CCI.19.00042.

5.

Validation of a Semiautomated Natural Language Processing-Based Procedure for Meta-Analysis of Cancer Susceptibility Gene Penetrance.

Deng Z, Yin K, Bao Y, Armengol VD, Wang C, Tiwari A, Barzilay R, Parmigiani G, Braun D, Hughes KS.

JCO Clin Cancer Inform. 2019 Aug;3:1-9. doi: 10.1200/CCI.19.00043.

6.

Decisional capacity to consent to treatment and anaesthesia in patients over the age of 60 undergoing major orthopaedic surgery.

Mandarelli G, Parmigiani G, Carabellese F, Codella S, Roma P, Brancadoro D, Ferretti A, Alessandro L, Pinto G, Ferracuti S.

Med Sci Law. 2019 Oct;59(4):247-254. doi: 10.1177/0025802419865854. Epub 2019 Aug 1. No abstract available.

PMID:
31366276
7.

Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome.

Kim J, Braun D, Ukaegbu C, Dhingra TG, Kastrinos F, Parmigiani G, Syngal S, Yurgelun MB.

Clin Gastroenterol Hepatol. 2019 Jul 15. pii: S1542-3565(19)30745-1. doi: 10.1016/j.cgh.2019.07.012. [Epub ahead of print]

PMID:
31319185
8.

Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer.

Hashim D, Gonzalez-Feliciano AG, Ahearn TU, Pettersson A, Barber L, Pernar CH, Ebot EM, Isikbay M, Finn SP, Giovannucci EL, Lis RT, Loda M, Parmigiani G, Lotan T, Kantoff PW, Mucci LA, Graff RE.

Int J Cancer. 2019 Jul 18. doi: 10.1002/ijc.32577. [Epub ahead of print]

PMID:
31318977
9.

Frequentist operating characteristics of Bayesian optimal designs via simulation.

Zhang Y, Trippa L, Parmigiani G.

Stat Med. 2019 Sep 20;38(21):4026-4039. doi: 10.1002/sim.8279. Epub 2019 Jun 19.

PMID:
31215685
10.

Deciphering the chronology of copy number alterations in Multiple Myeloma.

Aktas Samur A, Minvielle S, Shammas M, Fulciniti M, Magrangeas F, Richardson PG, Moreau P, Attal M, Anderson KC, Parmigiani G, Avet-Loiseau H, Munshi NC, Samur MK.

Blood Cancer J. 2019 Mar 26;9(4):39. doi: 10.1038/s41408-019-0199-3.

11.

The Admission Experience Survey Italian Version (I-AES): A factor analytic study on a sample of 156 acute psychiatric in-patients.

Mandarelli G, Parmigiani G, Trobia F, Tessari G, Roma P, Biondi M, Ferracuti S.

Int J Law Psychiatry. 2019 Jan - Feb;62:111-116. doi: 10.1016/j.ijlp.2018.12.006. Epub 2018 Dec 19.

PMID:
30616845
12.

Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration.

Wang Z, Cao S, Morris JS, Ahn J, Liu R, Tyekucheva S, Gao F, Li B, Lu W, Tang X, Wistuba II, Bowden M, Mucci L, Loda M, Parmigiani G, Holmes CC, Wang W.

iScience. 2018 Nov 30;9:451-460. doi: 10.1016/j.isci.2018.10.028. Epub 2018 Nov 2.

13.

Synergy of cytological methods in the pathological staging of breast cancer: Axillary fine-needle aspiration and intraoperative scrape cytology of the sentinel lymph node.

Bruzzone M, Saro F, Bruno S, Celiento T, Mazzarella G, Lanata S, Aquilano MC, Parmigiani G, Pollone M, Gandolfo F, Costigliolo G, Sironi M.

Diagn Cytopathol. 2018 Nov;46(11):919-926. doi: 10.1002/dc.23995. Epub 2018 Oct 24.

PMID:
30353679
14.

A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.

Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA.

Eur Urol. 2019 Jul;76(1):33-40. doi: 10.1016/j.eururo.2018.09.041. Epub 2018 Oct 6.

PMID:
30301696
15.

Multi-study factor analysis.

De Vito R, Bellio R, Trippa L, Parmigiani G.

Biometrics. 2019 Mar;75(1):337-346. doi: 10.1111/biom.12974. Epub 2019 Mar 8.

PMID:
30289163
16.

Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis.

Ma S, Ogino S, Parsana P, Nishihara R, Qian Z, Shen J, Mima K, Masugi Y, Cao Y, Nowak JA, Shima K, Hoshida Y, Giovannucci EL, Gala MK, Chan AT, Fuchs CS, Parmigiani G, Huttenhower C, Waldron L.

Genome Biol. 2018 Sep 25;19(1):142. doi: 10.1186/s13059-018-1511-4.

17.

The impact of different sources of heterogeneity on loss of accuracy from genomic prediction models.

Zhang Y, Bernau C, Parmigiani G, Waldron L.

Biostatistics. 2018 Sep 6. doi: 10.1093/biostatistics/kxy044. [Epub ahead of print]

PMID:
30202918
18.

Nonparametric Adjustment for Measurement Error in Time-to-Event Data: Application to Risk Prediction Models.

Braun D, Gorfine M, Katki HA, Ziogas A, Parmigiani G.

J Am Stat Assoc. 2018;113(521):14-25. doi: 10.1080/01621459.2017.1311261. Epub 2017 Sep 14.

19.

Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.

Chen GM, Kannan L, Geistlinger L, Kofia V, Safikhani Z, Gendoo DMA, Parmigiani G, Birrer M, Haibe-Kains B, Waldron L.

Clin Cancer Res. 2018 Oct 15;24(20):5037-5047. doi: 10.1158/1078-0432.CCR-18-0784. Epub 2018 Jul 3.

20.

Family History of Breast or Prostate Cancer and Prostate Cancer Risk.

Barber L, Gerke T, Markt SC, Peisch SF, Wilson KM, Ahearn T, Giovannucci E, Parmigiani G, Mucci LA.

Clin Cancer Res. 2018 Dec 1;24(23):5910-5917. doi: 10.1158/1078-0432.CCR-18-0370. Epub 2018 Aug 6.

PMID:
30082473
21.

Shared and Study-specific Dietary Patterns and Head and Neck Cancer Risk in an International Consortium.

De Vito R, Lee YCA, Parpinel M, Serraino D, Olshan AF, Zevallos JP, Levi F, Zhang ZF, Morgenstern H, Garavello W, Kelsey K, McClean M, Schantz S, Yu GP, Boffetta P, Chuang SC, Hashibe M, La Vecchia C, Parmigiani G, Edefonti V.

Epidemiology. 2019 Jan;30(1):93-102. doi: 10.1097/EDE.0000000000000902.

22.

Efficient computation of the joint probability of multiple inherited risk alleles from pedigree data.

Madsen T, Braun D, Peng G, Parmigiani G, Trippa L.

Genet Epidemiol. 2018 Sep;42(6):528-538. doi: 10.1002/gepi.22130. Epub 2018 Jun 25.

23.

Precision Prevention and Early Detection of Cancer: Fundamental Principles.

Rebbeck TR, Burns-White K, Chan AT, Emmons K, Freedman M, Hunter DJ, Kraft P, Laden F, Mucci L, Parmigiani G, Schrag D, Syngal S, Tamimi RM, Viswanath K, Yurgelun MB, Garber JE.

Cancer Discov. 2018 Jul;8(7):803-811. doi: 10.1158/2159-8290.CD-17-1415. Epub 2018 Jun 15.

24.

Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma.

Samur MK, Minvielle S, Gulla A, Fulciniti M, Cleynen A, Aktas Samur A, Szalat R, Shammas M, Magrangeas F, Tai YT, Auclair D, Keats J, Richardson P, Attal M, Moreau P, Anderson KC, Parmigiani G, Avet-Loiseau H, Munshi NC.

Leukemia. 2018 Dec;32(12):2626-2635. doi: 10.1038/s41375-018-0116-y. Epub 2018 Mar 29.

25.

Training replicable predictors in multiple studies.

Patil P, Parmigiani G.

Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2578-2583. doi: 10.1073/pnas.1708283115. Epub 2018 Mar 12.

26.

The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?

Vanderbeek AM, Rahman R, Fell G, Ventz S, Chen T, Redd R, Parmigiani G, Cloughesy TF, Wen PY, Trippa L, Alexander BM.

Neuro Oncol. 2018 Jul 5;20(8):1034-1043. doi: 10.1093/neuonc/noy027.

27.

A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations.

Braun D, Yang J, Griffin M, Parmigiani G, Hughes KS.

J Genet Couns. 2018 Sep;27(5):1187-1199. doi: 10.1007/s10897-018-0238-4. Epub 2018 Mar 2.

28.

Expressed fusion gene landscape and its impact in multiple myeloma.

Cleynen A, Szalat R, Kemal Samur M, Robiou du Pont S, Buisson L, Boyle E, Chretien ML, Anderson K, Minvielle S, Moreau P, Attal M, Parmigiani G, Corre J, Munshi N, Avet-Loiseau H.

Nat Commun. 2017 Dec 1;8(1):1893. doi: 10.1038/s41467-017-00638-w.

29.

Adding experimental arms to platform clinical trials: randomization procedures and interim analyses.

Ventz S, Cellamare M, Parmigiani G, Trippa L.

Biostatistics. 2018 Apr 1;19(2):199-215. doi: 10.1093/biostatistics/kxx030.

30.

Integrative factor analysis - An unsupervised method for quantifying cross-study consistency of gene expression data.

Wang XV, Parmigiani G.

Genomics. 2018 Mar;110(2):80-88. doi: 10.1016/j.ygeno.2017.08.009. Epub 2017 Sep 4.

31.

Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.

Tyekucheva S, Bowden M, Bango C, Giunchi F, Huang Y, Zhou C, Bondi A, Lis R, Van Hemelrijck M, Andrén O, Andersson SO, Watson RW, Pennington S, Finn SP, Martin NE, Stampfer MJ, Parmigiani G, Penney KL, Fiorentino M, Mucci LA, Loda M.

Nat Commun. 2017 Sep 4;8(1):420. doi: 10.1038/s41467-017-00460-4.

32.

Role of stem-cell divisions in cancer risk.

Tomasetti C, Durrett R, Kimmel M, Lambert A, Parmigiani G, Zauber A, Vogelstein B.

Nature. 2017 Aug 9;548(7666):E13-E14. doi: 10.1038/nature23302. No abstract available.

PMID:
28796214
33.

Reassessing risk models for atypical hyperplasia: age may not matter.

Mazzola E, Coopey SB, Griffin M, Polubriaginof F, Buckley JM, Parmigiani G, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi A, Hughes KS.

Breast Cancer Res Treat. 2017 Sep;165(2):285-291. doi: 10.1007/s10549-017-4320-7. Epub 2017 Jun 6. Review.

34.

Designing Clinical Trials That Accept New Arms: An Example in Metastatic Breast Cancer.

Ventz S, Alexander BM, Parmigiani G, Gelber RD, Trippa L.

J Clin Oncol. 2017 Sep 20;35(27):3160-3168. doi: 10.1200/JCO.2016.70.1169. Epub 2017 May 22.

PMID:
28530853
35.

[Mental capacity and capacity to consent: multicentric study in a involuntary psychiatric hospitalized patients sample].

Carabellese F, Mandarelli G, La Tegola D, Parmigiani G, Ferracuti S, Quartesan R, Bellomo A, Catanesi R.

Riv Psichiatr. 2017 Mar-Apr;52(2):67-74. doi: 10.1708/2679.27442. Italian.

PMID:
28492576
36.

MODELING DEPENDENT GENE EXPRESSION.

Telesca D, Müller P, Parmigiani G, Freedman RS.

Ann Stat. 2012;6(2):542-560. doi: 10.1214/11-AOAS525. Epub 2012 Jun 11.

37.

Propensity scores with misclassified treatment assignment: a likelihood-based adjustment.

Braun D, Gorfine M, Parmigiani G, Arvold ND, Dominici F, Zigler C.

Biostatistics. 2017 Oct 1;18(4):695-710. doi: 10.1093/biostatistics/kxx014.

38.

Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.

Tanguturi SK, Trippa L, Ramkissoon SH, Pelton K, Knoff D, Sandak D, Lindeman NI, Ligon AH, Beroukhim R, Parmigiani G, Wen PY, Ligon KL, Alexander BM.

Neuro Oncol. 2017 Jul 1;19(7):908-917. doi: 10.1093/neuonc/now312.

39.

Free will, neuroscience, and choice: towards a decisional capacity model for insanity defense evaluations.

Parmigiani G, Mandarelli G, Meynen G, Tarsitani L, Biondi M, Ferracuti S.

Riv Psichiatr. 2017 Jan-Feb;52(1):9-15. doi: 10.1708/2631.27049. Review.

PMID:
28287192
40.

Treatment decision-making capacity in non-consensual psychiatric treatment: a multicentre study.

Mandarelli G, Carabellese F, Parmigiani G, Bernardini F, Pauselli L, Quartesan R, Catanesi R, Ferracuti S.

Epidemiol Psychiatr Sci. 2018 Oct;27(5):492-499. doi: 10.1017/S2045796017000063. Epub 2017 Mar 9.

PMID:
28274298
41.

Bayesian response-adaptive designs for basket trials.

Ventz S, Barry WT, Parmigiani G, Trippa L.

Biometrics. 2017 Sep;73(3):905-915. doi: 10.1111/biom.12668. Epub 2017 Feb 17.

PMID:
28211944
42.

Combinatorial Mixtures of Multiparameter Distributions: An Application to Bivariate Data.

Edefonti V, Parmigiani G.

Int J Biostat. 2017 Feb 16;13(1). pii: /j/ijb.2017.13.issue-1/ijb-2015-0064/ijb-2015-0064.xml. doi: 10.1515/ijb-2015-0064.

PMID:
28207413
43.

Adaptive Randomization of Neratinib in Early Breast Cancer.

Harrington D, Parmigiani G.

N Engl J Med. 2016 Oct 20;375(16):1593-4. doi: 10.1056/NEJMc1609993. No abstract available.

PMID:
28103002
44.

Model averaged double robust estimation.

Cefalu M, Dominici F, Arvold N, Parmigiani G.

Biometrics. 2017 Jun;73(2):410-421. doi: 10.1111/biom.12622. Epub 2016 Nov 28.

45.

I-SPY 2--A Glimpse of the Future of Phase 2 Drug Development?

Harrington D, Parmigiani G.

N Engl J Med. 2016 Jul 7;375(1):7-9. doi: 10.1056/NEJMp1602256. No abstract available.

PMID:
27406345
46.

Decisional Capacity to Consent to Clinical Research Involving Placebo in Psychiatric Patients.

Parmigiani G, Mandarelli G, Dacquino C, Pompili P, Lelli Chiesa G, Ferracuti S.

J Forensic Sci. 2016 Mar;61(2):388-393. doi: 10.1111/1556-4029.13000. Epub 2015 Dec 22.

PMID:
27404612
47.

The Doppelgänger Effect: Hidden Duplicates in Databases of Transcriptome Profiles.

Waldron L, Riester M, Ramos M, Parmigiani G, Birrer M.

J Natl Cancer Inst. 2016 Jul 5;108(11). doi: 10.1093/jnci/djw146. Print 2016 Nov.

48.

Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk.

Marabelli M, Cheng SC, Parmigiani G.

Genet Epidemiol. 2016 Jul;40(5):425-31. doi: 10.1002/gepi.21971. Epub 2016 Apr 25.

PMID:
27112364
49.

A two-stage approach to genetic risk assessment in primary care.

Biswas S, Atienza P, Chipman J, Blackford AL, Arun B, Hughes K, Parmigiani G.

Breast Cancer Res Treat. 2016 Jan;155(2):375-83. doi: 10.1007/s10549-016-3686-2. Epub 2016 Jan 19.

50.

Familial Risk and Heritability of Cancer Among Twins in Nordic Countries.

Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, Graff RE, Holst K, Möller S, Unger RH, McIntosh C, Nuttall E, Brandt I, Penney KL, Hartman M, Kraft P, Parmigiani G, Christensen K, Koskenvuo M, Holm NV, Heikkilä K, Pukkala E, Skytthe A, Adami HO, Kaprio J; Nordic Twin Study of Cancer (NorTwinCan) Collaboration.

JAMA. 2016 Jan 5;315(1):68-76. doi: 10.1001/jama.2015.17703. Erratum in: JAMA. 2016 Feb 23;315(8):822.

Supplemental Content

Loading ...
Support Center